In human colorectal
adenomas or
polyps,
cyclooxygenase-2 is expressed predominantly by stromal (or interstitial) macrophages. Therefore, we tested the hypothesis that macrophage
cyclooxygenase-2 has paracrine pro-tumorigenic activity using in vitro models of macrophage-epithelial cell interactions. We report that macrophages can promote tumorigenic progression of intestinal epithelial cells (evidenced by decreased cell-cell contact inhibition, increased proliferation and apoptosis, gain of anchorage-independent growth capability, decreased membranous
E-cadherin expression, up-regulation of
cyclooxygenase-2 expression, down-regulation of
transforming growth factor-beta type II receptor expression and resistance to the anti-proliferative activity of
transforming growth factor-beta(1)) in a paracrine, cyclooxygenase-2-dependent manner. Pharmacologically relevant concentrations (1-2 microM) of a selective
cyclooxygenase-2 inhibitor had no detectable, direct effect on intestinal epithelial cells but inhibited the macrophage-epithelial cell signal mediating tumorigenic progression. Cyclooxygenase-2-mediated stromal-epithelial cell signalling during the early stages of intestinal
tumorigenesis provides a novel target for
chemoprevention of
colorectal cancer (and other gastro-intestinal epithelial
malignancies, which arise on a background of chronic
inflammation, such as
gastric cancer) and may explain the discrepancy between the concentrations of
cyclooxygenase inhibitors required to produce anti-neoplastic effects in vitro and in vivo.